La Crosse Virus Nucleocapsid (LACV N) (AA 90-140) Antikörper
Der Kaninchen Polyklonal anti-La Crosse Virus Nucleocapsid Antikörper wird verwendet zum Nachweis von La Crosse Virus Nucleocapsid in Proben von La Crosse Virus (LACV). Er wurde validiert für ELISA.
Kurzübersicht für La Crosse Virus Nucleocapsid (LACV N) (AA 90-140) Antikörper (ABIN6991880)
Target
La Crosse Virus Nucleocapsid (LACV N)
Reaktivität
La Crosse Virus (LACV)
Wirt
Kaninchen
Klonalität
Polyklonal
Konjugat
Unkonjugiert
Applikation
ELISA
Bindungsspezifität
AA 90-140
Aufreinigung
La Crosse Virus Nucleocapsid Antibody is affinity chromatography purified via peptide column.
Immunogen
La Crosse virus nucleocapsid antibody was raised against an 18 amino acid peptide near the center of the La Crosse virus nucleocapsid. The immunogen is located within amino acids 90 - 140 of La Crosse Virus Nucleocapsid.
LACV N
Reaktivität: Virus
ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
La Crosse virus nucleocapsid antibody can detect 10 ng La Crosse virus nucleocapsid peptide in ELISA at 1 μ,g/mL.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
La Crosse virus nucleocapsid Antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C,4 °C
Informationen zur Lagerung
Rift Valley Fever Virus Nucleocapsid antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
La Crosse Virus Nucleocapsid (LACV N)
Andere Bezeichnung
La Crosse Virus Nucleocapsid
Substanzklasse
Viral Protein
Hintergrund
La Crosse Virus Nucleocapsid Antibody: La Crosse virus (LCV) is a single-stranded RNA virus that can cause encephalitis in humans and is transmitted predominantly by mosquitoes. It is often mistaken for herpes simplex encephalitis (1). During human infections, LCV initially presents as a nonspecific summertime illness with fever, headache, nausea, vomiting and lethargy. Death occurs in less than 1 % of clinical cases.